NAD+ Decline: The Energy Problem Behind Cognitive Ageing
Every cell in your body needs it. Neurons need it more than most. And you have less of it every decade.
What is NAD+ and why does it decline with age?
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme required for mitochondrial ATP production in every cell. Levels decline steadily across adult life due to reduced synthesis, increased consumption by DNA repair enzymes responding to accumulated damage, and increased activity of NAD+-consuming enzymes. Because neurons consume roughly 20% of resting metabolic energy on 2% of body mass, declining NAD+ constrains them disproportionately.
What NAD+ does
Nicotinamide adenine dinucleotide is a coenzyme present in every cell. Its central role is electron transfer: it accepts electrons during the breakdown of glucose and fatty acids, then delivers them into the mitochondrial electron transport chain where the energy is captured as ATP.
Without adequate NAD+, oxidative phosphorylation slows. The same substrate yields less usable energy. In a cell with modest demands this is tolerable. In a neuron it is not.
Why neurons are especially vulnerable
The brain is roughly two percent of body mass and consumes approximately twenty percent of resting metabolic energy. That ratio is extraordinary, and it exists because neurons do expensive things continuously.
They maintain electrochemical gradients across their membranes at all times. They fire repeatedly. They sustain long-term potentiation, the synaptic strengthening that underlies memory formation. Every one of these is ATP-dependent, and neurons have minimal capacity to store energy substrate.
The decline
Falling NAD+ with age is one of the more consistently replicated findings in ageing biology. Several mechanisms converge.
Synthesis decreases. Consumption increases — DNA repair enzymes called PARPs consume NAD+ as they respond to accumulated genomic damage, and that damage accumulates with age. Other NAD+-consuming enzymes, including the sirtuins, also draw on the same pool.
The result is a shrinking supply meeting rising demand, in cells with no reserve.
The precursor pathways
The body synthesises NAD+ from several precursors. Niacin (nicotinic acid) is the most established and the most extensively documented, with decades of clinical use at pharmacological doses in lipid management and a correspondingly well-characterised safety and metabolic profile.
Nicotinamide riboside and nicotinamide mononucleotide have attracted substantial research and commercial attention more recently. They are effective precursors, generally more expensive, and with a shorter track record.
Niacin's advantage is the depth of its documentation. Its disadvantage is the flush — a harmless prostaglandin-mediated cutaneous vasodilation that some people find uncomfortable, though it diminishes with continued use.
What restoring NAD+ can and cannot do
Honest framing matters here, because NAD+ has attracted an unusual amount of longevity hype.
Reasonable: supplying precursor addresses one identifiable, substrate-limited constraint on cellular energy production. That is a specific and defensible claim.
Not reasonable: NAD+ restoration as an anti-ageing intervention that reverses cognitive decline. The mechanism addresses one component of a multi-factorial process. It does not reverse accumulated structural change, and human clinical outcome data remains considerably thinner than the marketing suggests.
Non-supplement approaches
Exercise increases NAD+ availability, partly through improved mitochondrial biogenesis. Caloric restriction and time-restricted eating have shown effects in animal models with less clear human translation. Reducing sources of DNA damage — UV exposure, smoking — reduces PARP-driven consumption.
As with most things in this area, the lifestyle interventions are less convenient and better evidenced than the supplement ones.
